Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11698172rdf:typepubmed:Citationlld:pubmed
pubmed-article:11698172lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:11698172lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11698172lifeskim:mentionsumls-concept:C0022567lld:lifeskim
pubmed-article:11698172lifeskim:mentionsumls-concept:C0043335lld:lifeskim
pubmed-article:11698172lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:11698172lifeskim:mentionsumls-concept:C0243102lld:lifeskim
pubmed-article:11698172lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11698172pubmed:issue6lld:pubmed
pubmed-article:11698172pubmed:dateCreated2001-11-7lld:pubmed
pubmed-article:11698172pubmed:abstractTextThis study analyses the expression and induction of several drug-metabolising enzyme activities involved in either phase I or phase II biotransformations in NCTC 2544 human keratinocytes. The phase I activities 7-ethoxycoumarin O-deethylase (ECOD), 7-ethoxyresorufin O-deethylase (EROD) and 7-pentoxyresorufin O-depenthylase (PROD) were easily detectable in basal conditions. During incubations lasting up to 144 h in the presence of the classical cytochrome P450 inducers beta-naphthoflavone (BNF), 3-methylcholanthrene (MC) and phenobarbital (PB), a considerable and significant increase in all the three activities was observed. PROD activity was induced up to 4.5-fold after 96 h in the presence of PB. The MC-induced ECOD and EROD activities were also dose-dependently inhibited by alpha-naphothflavone, which was given to the cells during the incubation with CYP 1A1 inducers. Also the PB-induced PROD activity was decreased by the simultaneous addition of the CYP 2B inhibitor metyrapone. Both cytochrome P450 inhibitors were used at non-cytotoxic concentrations. The phase II enzymes glutathione S-transferase, aldehyde dehydrogenase and quinone reductase were all highly expressed and inducible by MC. The exposure (24 h) of the cells to four hair dyes used in cosmetic formulations resulted in a marked increase in ECOD activity. All data give sustained evidence for the suitability of NCTC 2544 cell line to skin toxicology studies.lld:pubmed
pubmed-article:11698172pubmed:languageenglld:pubmed
pubmed-article:11698172pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:citationSubsetIMlld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11698172pubmed:statusMEDLINElld:pubmed
pubmed-article:11698172pubmed:monthDeclld:pubmed
pubmed-article:11698172pubmed:issn0887-2333lld:pubmed
pubmed-article:11698172pubmed:authorpubmed-author:MorinoHHlld:pubmed
pubmed-article:11698172pubmed:authorpubmed-author:PencoSSlld:pubmed
pubmed-article:11698172pubmed:authorpubmed-author:FerroMMlld:pubmed
pubmed-article:11698172pubmed:authorpubmed-author:GelardiAAlld:pubmed
pubmed-article:11698172pubmed:authorpubmed-author:DusattiFFlld:pubmed
pubmed-article:11698172pubmed:issnTypePrintlld:pubmed
pubmed-article:11698172pubmed:volume15lld:pubmed
pubmed-article:11698172pubmed:ownerNLMlld:pubmed
pubmed-article:11698172pubmed:authorsCompleteYlld:pubmed
pubmed-article:11698172pubmed:pagination701-11lld:pubmed
pubmed-article:11698172pubmed:dateRevised2009-4-10lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:meshHeadingpubmed-meshheading:11698172...lld:pubmed
pubmed-article:11698172pubmed:year2001lld:pubmed
pubmed-article:11698172pubmed:articleTitleInduction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544.lld:pubmed
pubmed-article:11698172pubmed:affiliationDepartment of Experimental Medicine, General Pathology Division, University of Genoa, Via L.B. Alberti, 2, 16132, Genova, Italy.lld:pubmed
pubmed-article:11698172pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11698172lld:pubmed